Tribhuvan University Teaching Hospital
Maharajgunj, Bagmati, 9771, Nepal
NCT Number: NCT06824311
The main aim of this study is to know about the clinical profile of patients who are diagnosed as hemorrhagic stroke as well as the factors that affect good and bad outcomes of those patients after 3 months. Patients will be required to follow up in medical OPD of the same institution after 3 months.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Maharajgunj, Bagmati, 9771, Nepal
This was a prospective observational study conducted on 197 patients of ≥ 18 years of age admitted with the diagnosis of hemorrhagic stroke in Tribhuvan University Teaching Hospital, a tertiary hospital in Nepal from April 1 2023 to March 31, 2024. Patients who do not give consent or with post-traumatic hemorrhages, hemorrhagic transformation of an ischemic stroke, or any intracranial hemorrhages other than primary intracranial hemorrhages were excluded from the study. The study protocol and design were reviewed and approved by the Institutional Review Committee of Tribhuvan University Teaching Hospital [Ref. 437 (6-11) E2]. Data was collected in a structured proforma.
The primary outcome of this study was to assess the functional outcome of the patients at 3 months of follow-up. The modified Rankin scale (mRS) was assessed in an outpatient setting during the follow-up. If patients did not attend the 3-month follow-up, mRS was assessed by telephone conversation. Clinical outcome was dichotomously categorized as good outcome if mRS was 0-2 and bad outcome if mRS was ≥ 3.
Analysis for categorical data was done by Chi-squared test, Fisher's exact test. Analysis for continuous data was done using either parametric tests like the t-test, or non-parametric tests like the Mann-Whitney U test depending on the distribution of data. Predictors of clinical outcomes were analyzed using multivariate logistic regression.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From the diagnosis of hemorrhagic stroke to 3 months of follow up
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05458908
Brain Diseases, Cardiovascular Diseases
Denver, Colorado, United States
View Trial DetailsNCT05419193
Brain Diseases, Cardiovascular Diseases
Lu'an, Anhui, China
View Trial DetailsNCT04569279
Brain Diseases, Cardiovascular Diseases
Damascus, Damascus Governorate, Syria
View Trial DetailsNCT01584180
Body Temperature Changes, Brain Diseases
Heidelberg, Germany
View Trial Details